Literature DB >> 7753852

Bridging grafts and transient nerve growth factor infusions promote long-term central nervous system neuronal rescue and partial functional recovery.

M H Tuszynski1, F H Gage.   

Abstract

Grafts of favorable axonal growth substrates were combined with transient nerve growth factor (NGF) infusions to promote morphological and functional recovery in the adult rat brain after lesions of the septohippocampal projection. Long-term septal cholinergic neuronal rescue and partial hippocampal reinnervation were achieved, resulting in partial functional recovery on a simple task assessing habituation but not on a more complex task assessing spatial reference memory. Control animals that received transient NGF infusions without axonal-growth-promoting grafts lacked behavioral recovery but also showed long-term septal neuronal rescue. These findings indicate that (i) partial recovery from central nervous system injury can be induced by both preventing host neuronal loss and promoting host axonal regrowth and (ii) long-term neuronal loss can be prevented with transient NGF infusions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753852      PMCID: PMC41996          DOI: 10.1073/pnas.92.10.4621

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Alternation and exploration in rats with hippocampal lesions.

Authors:  W W ROBERTS; W N DEMBER; M BRODWICK
Journal:  J Comp Physiol Psychol       Date:  1962-10

2.  Expression of growth factor receptors in injured nervous tissue. I. Axotomy leads to a shift in the cellular distribution of specific beta-nerve growth factor binding in the injured and regenerating PNS.

Authors:  G Raivich; G W Kreutzberg
Journal:  J Neurocytol       Date:  1987-10

3.  Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppression by axonal contact, and binding properties.

Authors:  M Taniuchi; H B Clark; J B Schweitzer; E M Johnson
Journal:  J Neurosci       Date:  1988-02       Impact factor: 6.167

4.  Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections.

Authors:  F Hefti
Journal:  J Neurosci       Date:  1986-08       Impact factor: 6.167

5.  Age differences in within-session habituation of exploratory behavior: effects of stimulus complexity.

Authors:  M J Brennan; D Allen; D Aleman; E C Azmitia; D Quartermain
Journal:  Behav Neural Biol       Date:  1984-09

6.  Axons from CNS neurons regenerate into PNS grafts.

Authors:  P M Richardson; U M McGuinness; A J Aguayo
Journal:  Nature       Date:  1980-03-20       Impact factor: 49.962

7.  Nerve growth factor treatment after brain injury prevents neuronal death.

Authors:  L F Kromer
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

8.  Regeneration of rat hippocampal fimbria fibers after fimbria transection and peripheral nerve or fetal hippocampal implantation.

Authors:  J S Wendt; G E Fagg; C W Cotman
Journal:  Exp Neurol       Date:  1983-02       Impact factor: 5.330

9.  Hippocampal mossy fiber distribution covaries with open-field habituation in the mouse.

Authors:  W E Crusio; H Schwegler
Journal:  Behav Brain Res       Date:  1987 Nov-Dec       Impact factor: 3.332

10.  Developments of a water-maze procedure for studying spatial learning in the rat.

Authors:  R Morris
Journal:  J Neurosci Methods       Date:  1984-05       Impact factor: 2.390

View more
  18 in total

1.  Robust CNS regeneration after complete spinal cord transection using aligned poly-L-lactic acid microfibers.

Authors:  Andres Hurtado; Jared M Cregg; Han B Wang; Dane F Wendell; Martin Oudega; Ryan J Gilbert; John W McDonald
Journal:  Biomaterials       Date:  2011-06-01       Impact factor: 12.479

Review 2.  Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.

Authors:  Seung T Lim; Mikko Airavaara; Brandon K Harvey
Journal:  Pharmacol Res       Date:  2009-10-17       Impact factor: 7.658

Review 3.  Genetic therapy for the nervous system.

Authors:  William J Bowers; Xandra O Breakefield; Miguel Sena-Esteves
Journal:  Hum Mol Genet       Date:  2011-03-23       Impact factor: 6.150

4.  A single re-implanted ventral root exerts neurotropic effects over multiple spinal cord segments in the adult rat.

Authors:  Thao X Hoang; Leif A Havton
Journal:  Exp Brain Res       Date:  2005-11-05       Impact factor: 1.972

Review 5.  Maintaining the neuronal phenotype after injury in the adult CNS. Neurotrophic factors, axonal growth substrates, and gene therapy.

Authors:  M H Tuszynski; F H Gage
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

Review 6.  Alzheimer disease.

Authors:  Rudy J Castellani; Raj K Rolston; Mark A Smith
Journal:  Dis Mon       Date:  2010-09       Impact factor: 3.800

7.  Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.

Authors:  Edward Rockenstein; Kiren Ubhi; Emiley Pham; Sarah Michael; Edith Doppler; Philipp Novak; Chandra Inglis; Michael Mante; Anthony Adame; X Anton Alvarez; Herbert Moessler; Eliezer Masliah
Journal:  J Neurosci Res       Date:  2011-07-25       Impact factor: 4.164

8.  Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity.

Authors:  W F Goins; K A Lee; J D Cavalcoli; M E O'Malley; S T DeKosky; D J Fink; J C Glorioso
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain.

Authors:  M J Mahoney; W M Saltzman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

10.  Chemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury.

Authors:  Laura Taylor Alto; Leif A Havton; James M Conner; Edmund R Hollis; Armin Blesch; Mark H Tuszynski
Journal:  Nat Neurosci       Date:  2009-08-02       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.